Skip to main content

Table 2 Crude and age-adjusted overall and gender-specific thyroid cancer prevalence (95% CI) among patients with thyroid nodules who underwent ultrasound guided fine needle aspiration (UG-FNA) biopsy between January 2011 and December 2015 in a tertiary hospital in Abu Dhabi, United Arab Emirates

From: Thyroid malignancy among patients with thyroid nodules in the United Arab Emirates: a five-year retrospective tertiary Centre analysis

  Crude Cancer Prevalence % (95% CI)  
  Overall Women Men p-value*
N (cancer/No cancer) 44/392 34/333 10/59  
All thyroid nodules 10.1 (7.5–13.3) 9.3 (6.3–12.2) 14.5 (6.2–22.8) 0.186
Age (years)
18–29 years 16.7 (6.7–26.6) 15.2 (4.8–25.6) 25.0 (0.0–55.0) 0.493
30–39 years 8.8 (3.6–14.0) 8.3 (3.1–13.5) 16.7 (0.0–46.5) 0.482
40–49 years 12.0 (6.5–17.6) 11.0 (5.1–16.9) 16.7 (1.8–31.6) 0.441
50–59 years 5.2 (0.2–10.2) 5.0 (0.0–10.5) 5.9 (0.0–17.1) 0.885
  ≥ 60 years 8.6 (1.4–15.8) 6.8 (0.0–14.3) 14.3 (0.0–32.6) 0.386
Ethnicity**
UAE 9.5 (3.6–15.4) 7.7 (1.8–13.6) 17.6 (0.0–35.8) 0.204
Arabs 10.4 (6.5–14.2) 10.1 (5.9–14.3) 11.6 (2.0–21.2) 0.766
Far-East Asians 16.7 (4.5–28.8) 12.1 (1.0–23.3) 66.7 (13.3–99.9) 0.015
Caucasians 15.4 (1.5–29.3) 16.0 (1.6–30.4) 0  
  Age-adjusted Cancer Prevalence % (95% CI)  
All thyroid nodules 10.0 (7.7–12.8) 9.0 (6.0–11.9) 15.1 (6.5–23.8) 0.117
Ethnicitya
UAE 9.6 (3.6–15.6) 7.7 (1.8–13.7) 18.7 (0.0–37.9) 0.166
Arabs 10.0 (6.2–13.8) 9.7 (5.5–13.8) 10.9 (1.5–20.4) 0.799
Far-East Asians 16.8 (4.5–29.0) 12.3 (1.0–23.6) 65.1 (10.4–99.9) 0.019
Caucasians 16.3 (1.7–30.9) 17.0 (1.8–32.1) 0  
  1. *p-value comparing women vs men
  2. aNo cancerous nodules in patients of South-East Asians/Other ethnicities